82%
Finnrick rating
#2 of 57 Semaglutide vendors
9 of 9 classifiable tests passed
natural 100%
methodology · Purity focus
Finnrick analysis · Semaglutide

Paramount's semaglutide rates well on consistent identity and >99.5% purity, with fills inside this method's wide limit. Caveats are aging evidence, high overfills including +34%, and recurring missing batch IDs.

methodology →
vendor intelligence report
Vendor Intelligence Report: Paramount Peptides

We investigated who actually operates Paramount Peptides — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.

26 pages5 risk factors assessed12 Jun 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Retatrutide
$20.83
84%
12
2
Semaglutideselected
$22.50
82%
9
3
Ipamorelin
$8.00
75%
7
4
Tirzepatide
$20.00
73%
11
5
PT-141
$5.50
63%
3
6
BPC-157
$7.50
52%
11
7
Survodutide
$37.50
47%
3
8
CJC-1295
$7.50
30%
9
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%14 Jan 2025: 81%23 Jan 2025: 87%27 Feb 2025: 87%28 Feb 2025: 88%28 Feb 2025: 89%20 Mar 2025: 89%25 Apr 2025: 88%6 May 2025: 89%6 May 2025: 90%9 Aug 2026: current 82%81%82%Jan 25Aug 26
Showing Semaglutide tests only
Paramount Peptides Semaglutide test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
6 May 2025Pass
Tested
lab nameView COA
6 May 2025Pass
Tested
lab nameView COA
25 Apr 2025Pass
Tested
lab nameView COA
20 Mar 2025Pass
Tested
lab nameView COA
28 Feb 2025Pass
Tested
lab nameView COA
28 Feb 2025Pass
Tested
lab nameView COA
27 Feb 2025Pass
Tested
lab nameView COA
23 Jan 2025Pass
Tested
lab nameView COA
14 Jan 2025Pass
Tested
lab nameView COA

About Paramount Peptides test results from Finnrick

Paramount Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 8 peptides and 65 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Paramount Peptides peptides in this dataset are Semaglutide (9 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 65 recent tests.

Corrections
No corrections.